Fougera Pharmaceuticals Inc.

Pharmaderm
60 Baylis Rd
Melville, NY, 11747-3838  United States
(631) 454-7677
Company Type: Corporation Subsidiary

D&B Business Directory

Fougera Pharmaceuticals (formerly Nycomed US) is focused on making specialty topical and dermatology medicines for North Americans. The company's E. Fougera & Company division primarily makes generic topical steroids, antibiotics, and antifungals for both prescription and OTC markets, while the PharmaDerm unit develops, manufactures, and markets branded prescription dermatology products. Its smaller Savage Laboratories unit makes prescription topicals for the emergency care market. Fougera separated from former parent Nycomed International in 2011 when it was bought by an investment group led by Nordic Capital. Investors sold Fougera to Sandoz in 2012.

Try D&B Hoovers Free

Fougera Pharmaceuticals Inc.

Corporation Subsidiary
Doing Business As
Pharmaderm
Address
60 Baylis Rd
Melville ​, NY, 11747-3838
United States
See other locations
Phone
(631) 454-7677
Company Description

Fougera Pharmaceuticals (formerly Nycomed US) is focused on making specialty topical and dermatology medicines for North Americans. The company's E. Fougera & Company division primarily makes generic topical steroids, antibiotics, and antifungals for both prescription and OTC markets, while the PharmaDerm unit develops, manufactures, and markets branded prescription dermatology products. Its smaller Savage Laboratories unit makes prescription topicals for the emergency care market. Fougera separated from former parent Nycomed International in 2011 when it was bought by an investment group led by Nordic Capital. Investors sold Fougera to Sandoz in 2012.

Key Principal
Brian A Markison See more contacts
Industry
Pharmaceutical Manufacturing Manufacturing Sector Druggists' preparations (pharmaceuticals) Ointments Paints and paint additives Plasticizer/additive based plastic materials Painting, coating, and hot dipping Measuring and controlling devices, nec See all industries
D&B Hoovers Logo

For dynamic search and list-building capabilities, real-time trigger alerts, comprehensive company profiles, and valuable research and technology reports try D&B Hoovers for free!

Financial Statements

Revenue in USD

Annual Revenue2018
$284.33 million USD

Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.

Competitor Profiles

See detailed profiles for insights and prospects on this company's top competitors.

Company Snapshot

Essential information for a successful call

  •  EMPLOYEES (This Site) 250
  •  EMPLOYEES (All Sites) 880
  •  REVENUE (MIL USD) 284.33
  • Year Started 1963
  • Incorporated 1998
  • FISCAL YEAR END NOV

Get in Touch with 6 Principals* and 114 Contacts

A D&B Hoovers Subscription is your foot in the door to Fougera Pharmaceuticals Inc. contact information.
  • Brian A Markison
    Chief Executive Officer
  • DONALD DEGOLYER
    Chairman of the Board
  • DAVID RIPOSO
    Vice President and Treasurer
  • JEFF BAILEY
    Chief Operating Officer

Want more contacts like these available directly in your inbox? Install D&B Email IQ to access your next prospects!

Free Install

Related Products

Grow Business FasterLearn More
D&B Finance Analytics Credit IntelligenceIntelligent Risk ManagementLearn More
Free Microsoft Outlook plugin to drive efficiency with on-demand sales intelligenceFree Install

Get full access to D&B Hoovers

With a Hoovers subscription you can get a comprehensive view of Fougera Pharmaceuticals Inc.

Fougera Pharmaceuticals Inc.*

6
Principals
See who the company's key decision makers are
114
Contacts
Reach the right people with access to detailed contact information.
756
Corporate Relations
Get the big picture on a company's affiliates and who they do business with.
7
Close Industry Peers
See similar companies for insight and prospecting.
*Contacts and Principals counts are estimates and may differ from the actual number of contacts available in D&B Hoovers.